Winston Dunn, MD, FAASLD
Professor of Medicine, Division of Gastroenterology, University of Kansas Medical Center

Dr. Winston Dunn is a hepatologist and Professor of Medicine at the University of Kansas Medical Center, specializing in metabolic dysfunction–associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and advanced fibrosis. His research integrates clinical epidemiology, real-world data, and machine learning to improve noninvasive diagnostics and patient stratification for therapeutic trials.

Elisabetta Degasperi serves as Hepatologist at the Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
After graduation in Medicine in 2010 at the University of Milan, she specialized in Gastroenterology in 2016 and received her PhD in Clinical and Experimental Medicine in 2020 at the University of Milan.

Longgang Zhao is a postdoctoral researcher at Yale School of Nursing with expertise in nutritional epidemiology and cancer prevention. His research centers on the role of diet, metabolism, and inflammation in the development of liver disease and liver cancer.

Director of Translational Science

Lara is SVP, Head of Research and Translational Science at Resolution Therapeutics, a spin-out of the University of Edinburgh. Her long-term research interest is the role of regenerative macrophages in tissue repair, and how to translate their therapeutic potential to treat chronic inflammatory diseases with a fibrotic component. In her role at Resolution, she sets the Research strategy and oversees its execution to promote the progression of the lead asset RTX001 through the preclinical and clinical stages.